CKChris Kent

Chris Kent

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Chris Kent has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    artic-bdbv-2026/400/v1.0.0 Protocol v1

    by Chris Kent, Dominika Stepniak, Charlotte Pratt, Josh Quick

    This protocol describes how to prepare the primer pools for the artic-bdbv-2026/400/v1.0.0 amplicon scheme (48 amplicons of ~400 bp in 2 pools), generate cDNA using LunaScript RT, and run the multiplex PCR. Downstream library preparation follows the ARTIC LoCost Amplicon Sequencing Protocol (SQK-NBD114). The primer scheme is available from Primal Scheme Labs: https://labs.primalscheme.com/detail/artic-bdbv-2026/400/v1.0.0

  • Open Access

    artic-pan-ebola/1000/v2.0.0 Protocol v1

    by Chris Kent, Dominika Stepniak, Charlotte Pratt, Josh Quick

    This protocol describes how to prepare the primer pools for the artic-pan-ebola/1000/v2.0.0 amplicon scheme (19 amplicons of ~1000 bp in 2 pools), generate cDNA using LunaScript RT, and run the multiplex PCR. Downstream library preparation follows the ARTIC LoCost Amplicon Sequencing Protocol (SQK-NBD114). The primer scheme is available from Primal Scheme Labs: https://labs.primalscheme.com/detail/artic-pan-ebola/1000/v2.0.0

  • Open Access

    Pathogen detection in central nervous system infections: moving metagenomic sequencing closer to clinical practice

    by Nicola Cumley, Josh Quick, Thomas Brier, Sam Wilkinson, Chris Kent, Zaki Hassan-Smith, Nicholas Loman, Ghaniah Hassan-Smith

    Background: Central nervous system infections (CNSI) contribute significantly to global disability and mortality, but the causative agent is often undetected. Metagenomic sequencing offers the potential to enhance diagnostic sensitivity, particularly in cases of unusual or partially treated infections. However, caution is required in interpretation of metagenomics data due to technical artefacts from contamination or non-specific read mapping which can reveal a broad spectrum of biologically plausible but diagnostically unlikely organisms. Methods: This study compares the performance of metagenomic sequencing with standard clinical microbiology methods using cerebrospinal fluid (CSF) from patients with CNSI and non-infected control samples. To evaluate sensitivity of different laboratory approaches, we sequenced DNA and RNA metagenomic libraries extracted from CSF, using both cell-free and cellular fractions. We then devised a set of simple, easily interpreted yet rigorous filters tailored for clinical metagenomics to generate a framework for result interpretation that can be readily applied by clinical scientists. Results: We demonstrate that composite filtering strategies are essential to reduce misleading signals and support standardised workflows. Additionally, our results suggest that a cell-free sample preparation approach can improve confidence in identifying clinically relevant pathogens, highlighting the impact of sample preparation on results quality. Conclusion: In this study we describe a reproducible method that can be incorporated into a practical framework for clinical application of metagenomic sequencing in CNSI diagnostics.


  • Open Access

    Reducing Supply Chain Dependencies for Viral Genomic Surveillance: Get by with a Little HELP from Commercial Enzymes already in your Lab Freezer

    by Ganna Kovalenko, Myra Hosmillo, Chris Kent, Kess Rowe, Andrew Rambaut, Nicholas J Loman, Joshua Quick, Ian Goodfellow

    Background The COVID-19 pandemic exposed critical vulnerabilities in global laboratory supply chains, disrupting the availability of key reagents and jeopardising the continuity of genomic surveillance for epidemic response. Sustaining sequencing capacity during shortages requires locally accessible alternatives to commercial kits. Methods We developed ARTIC HELP (Homebrew Enzymes for Library Preparation), an open-source adaptation of the ARTIC nanopore sequencing protocol for viral genomic surveillance. We described cost-effective, generic replacements for enzyme mixes used in tiling multiplex RT-PCR and the nanopore native barcoding workflow, including end-prep (EP), barcode ligation (BL), and adapter ligation (AL). Through systematic evaluation, we tested wild-type M-MLV reverse transcriptase and two types of proofreading DNA polymerases, (i) B-family Pfu-based polymerases fused to an Sso7d DNA-binding domain, and (ii) blends of A-family (Taq-based) and B-family (Pfu-based) polymerases, against standard reagents. We validated the workflow on clinical SARS-CoV-2 and Norovirus GII samples. Results The HELP workflow delivered genome coverage comparable to the ARTIC LoCost protocol. For SARS-CoV-2 samples (Ct ≤28), wild-type M-MLV RT combined with selected Pfu or AB blend polymerases, alongside optimized HELP EP, BL, and AL mixes, achieved 84.0–99.6% genome coverage. For Norovirus GII samples (Ct ≤32), the HELP workflow enabled >85% coverage across six of eight genotypes tested. While some polymerases showed reduced performance at higher Ct values, they performed reliably at Ct <24, supporting their use as emergency alternatives when viral load is high and RNA quality sufficient. Conclusions ARTIC HELP provides a practical and flexible solution to maintain viral sequencing capacity when standard ARTIC LoCost reagents are inaccessible or unaffordable. Our cost analysis highlights global disparities in reagent pricing, likely influenced by import fees, supply barriers, and local procurement conditions, underscoring the need for more equitable pricing models and local sourcing strategies. By expanding reagent options, ARTIC HELP strengthens preparedness for future global health emergencies.


  • Open Access

    Integrating measles wastewater and clinical whole-genome sequencing enables high-resolution tracking of virus evolution and transmission

    by Sipho Gwala, Joshua I. Levy, Victor V Mabasa, Kathleen Subramoney, Nkosenhle L. Ndlovu, Chris Kent, Maryam Ahmadi Jeshvaghane, Praneeth Gangavarapu, Menzi Sikakane, Natasha Singh, et al.

    Measles outbreaks have surged globally in recent years, but current surveillance systems have limited capacity to monitor measles virus (MeV) transmission and evolution at population scale. Although MeV can be detected in wastewater, the public health potential of wastewater genomic surveillance for MeV remains largely unexplored. Here, we deploy sensitive, low-cost MeV wastewater genomic surveillance combining virus concentration, whole-genome amplicon sequencing, and bioinformatic analysis alongside routine clinical genomic surveillance during the 2024-25 outbreak in South Africa. Integrated phylogenetic analyses of wastewater and clinical MeV genomes revealed previously undetected interprovincial spread and transmission links not captured by standard N450 sequencing. Our findings demonstrate that wastewater-integrated whole-genome surveillance expands the coverage and resolution of routine MeV monitoring and provides a scalable tool to advance measles control and elimination efforts.


  • Open Access

    Human outbreak detection and best practice MPXV analysis and interpretation with squirrel

    by Áine O’tOole, Eddy Kinganda-Lusamaki, Rachel Colquhoun, Connor Chato, Emily Scher, Chris Kent, Sam Wilkinson, Joshua Quick, Nicholas Loman, Ana T Duggan, et al.

    High numbers of reported mpox cases and recent identification of multiple sustained human outbreaks of mpox virus (MPXV) have highlighted the need for robust, best-practice genomic surveillance tools. In light of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, many labs across the globe developed the capacity to do virus genome sequencing; however, MPXV presents additional analytical challenges due to its large genome size, tracts of low-complexity or repeat regions, genetically distinct clades, and the need to perform bespoke apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3 (APOBEC3)-mutation reconstruction. We present squirrel (Some Quick Reconstruction to Resolve Evolutionary Links), an open source bioinformatic tool that can perform clade-aware alignment, mutation quality assessment, phylogenetic inference, and automated APOBEC3-mutation classification on branches of the phylogeny. Squirrel can be run on the command line or launched through the EPI2ME graphical user interface through the squirrel-nf workflow, enabling robust analysis without need for the command line. With the interactive output report produced and publication-ready APOBEC3-reconstruction visualization, squirrel enables researchers to distinguish between zoonotic and sustained human outbreaks and help accurately inform public health responses.


  • Open Access

    Reducing Supply Chain Dependencies for Viral Genomic Surveillance: Get by with a Little HELP from Commercial Enzymes already in your Lab Freezer

    by Ganna Kovalenko, Myra Hosmillo, Chris Kent, Kess Rowe, Andrew Rambaut, Nicholas J Loman, Joshua Quick, Ian Goodfellow

    Background The COVID-19 pandemic exposed critical vulnerabilities in global laboratory supply chains, disrupting the availability of key reagents and jeopardising the continuity of genomic surveillance essential for epidemic response. Sustaining sequencing capacity during supply shortages requires practical, locally accessible alternatives to commercial kits. Methods We developed ARTIC HELP (Homebrew Enzymes for Library Preparation), an open-source adaptation of the ARTIC nanopore sequencing protocol for viral genomic surveillance. We described cost-effective, generic replacements for all enzyme mixes used in tiling multiplex RT-PCR and the nanopore native barcoding workflow, including end-prep (EP), barcode ligation (BL), and adapter ligation (AL). Through systematic evaluation, we tested wild-type M-MLV reverse transcriptase and two types of proofreading DNA polymerases, (i) B-family Pfu-based polymerases fused to an Sso7d DNA-binding domain, and (ii) blends of A-family (Taq-based) and B-family (Pfu-based) polymerases, against standard reagents. We validated the workflow on clinical SARS-CoV-2 and Norovirus GII samples. Results The HELP workflow delivered genome coverage comparable to the ARTIC LoCost protocol. For SARS-CoV-2 samples (Ct ≤28), wild-type M-MLV RT combined with selected Pfu or AB blend polymerases, alongside optimized HELP EP, BL, and AL mixes, achieved 84.0–99.6% genome coverage. For Norovirus GII samples (Ct ≤32), the HELP workflow enabled >85% coverage across six of eight genotypes tested. While some polymerases showed reduced performance at higher Ct values, they performed reliably at Ct <24, supporting their use as emergency alternatives in rapid outbreak-response sequencing when viral load is high and RNA quality sufficient. Conclusions ARTIC HELP provides a robust and flexible solution to maintain viral sequencing capacity when standard reagents are inaccessible or unaffordable. Our cost analysis highlights stark global disparities in reagent pricing driven by import fees and supply barriers, rather than protocol complexity, underscoring the need for equitable pricing models and local sourcing strategies. By giving laboratories more options for essential reagents, ARTIC HELP strengthens preparedness and resilience for future public health emergencies.

  • Open Access

    Reducing Supply Chain Dependencies for Viral Genomic Surveillance: Get by with a Little HELP from Commercial Enzymes already in your Lab Freezer

    by Ganna Kovalenko, Myra Hosmillo, Chris Kent, Kess Rowe, Andrew Rambaut, Nicholas J Loman, Joshua Quick, Ian Goodfellow

    The COVID-19 pandemic exposed vulnerabilities in global laboratory supply chains, disrupting genomic surveillance efforts essential to epidemic response. To address this challenge, we developed ARTIC HELP (Homebrew Enzymes for Library Preparation), a practical, open-source adaptation of the widely adopted ARTIC nanopore sequencing protocol for viral genomic surveillance. We describe generic, cost-effective alternatives to all enzyme mixes used in tiling multiplex RT-PCR amplification of the virus genome, and the nanopore native barcoding workflow, including end-prep (EP), barcode ligation (BL), and adapter ligation (AL), making it broadly applicable to any laboratory. Through systematic evaluation, we identified a wild-type M-MLV reverse transcriptase and two types of proofreading DNA polymerases as effective alternatives when standard reagents are unavailable due to high cost or limited supply: B-family Pfu-based polymerases with a fused Sso7d DNA-binding domain, and blends combining A-family (Taq-based) and B-family (Pfu-based) polymerases. Validation on clinical samples of SARS-CoV-2 and Norovirus GII confirmed that the HELP workflow achieves genome coverage comparable to the ARTIC LoCost protocol. For SARS-CoV-2 samples (Ct ≤28), the wild-type M-MLV RT combined with selected Pfu or A+B polymerases, along with optimised HELP mixes (EP, BL, AL), achieved genome coverage of 84.0–99.6%. For Norovirus GII (Ct ≤32), the HELP workflow using one of the Pfu polymerases achieved genome coverage of >85% for six out of eight genotypes tested. Notably, several of the other polymerases tested showed reduced performance at higher Ct values. However, they still achieved strong coverage at Ct <24, supporting their use as emergency alternatives in rapid outbreak-response sequencing when viral input is high and RNA quality is sufficient. Our approach, ARTIC HELP, provides a framework which can be implemented to address supply chain disruptions, while maintaining robust genomic sequencing capabilities. A cost analysis highlights the well-known significant global disparities in reagent pricing, driven not by protocol differences but by import fees and supply barriers. Thus, our findings highlight the need for fairer global pricing models and support for local sourcing strategies like HELP, to promote equity in genomic research and ensure preparedness for future public health challenges.


  • Open Access

    PrimalScheme: open-source community resources for low-cost viral genome sequencing

    by Chris Kent, Andrew D Smith, John Tyson, Dominika Stepniak, Eddy Kinganda-Lusamaki, Tracy Lee, Mia Weaver, Natalie Sparks, Lauren Landsdowne, Sam Aj Wilkinson, et al.

    Viral genome sequencing using the ARTIC protocol has been a vital tool for understanding the spread of epidemics including Ebola, Zika, COVID-19 and Mpox and has seen widespread adoption due to its low cost and high sensitivity. Here, we describe PrimalScheme, an open-source toolkit and website that allows users to easily design primer schemes for amplicon sequencing of viruses and has generated over 67,000 primer schemes for a global community since 2017. In January 2020, PrimalScheme was used to rapidly generate a primer scheme for SARS-CoV-2, with primer pools distributed to researchers from 44 countries to help scale-up genomic surveillance efforts. Overall, these primers were used to generate an estimated 18M genome sequences and the protocols were viewed online ~250K times. To complement PrimalScheme, we have built PrimalScheme Labs, a scheme repository which allows users to find and share primers schemes as well as establishing a set of data standards. Through improvements to the primer design process, including the use of discrete primer clouds, we have expanded the use of amplicon sequencing to include diverse virus species. We demonstrate the utility of this approach through a high diversity pan-genotype Measles virus (MeV) scheme. We also demonstrate its use on a high sensitivity, short amplicon Monkeypox virus (MPXV) scheme with over 1000 primers, showing high genome recovery on low-titre clinical samples. These developments have implications for sequencing from samples such as wastewater, for genomic surveillance of endemic pathogens and in preparing for future pandemics.


  • Open Access

    HEP-TILE: HBV whole genome sequencing (nanopore protocol) v2

    by Sheila Lumley, Josh Quick, Philippa Matthews, Chris Kent

    This protocol describes the HEP-TILE tiled amplicon protocol for whole genome sequencing of Hepatitis B virus (HBV) on the nanopore MinION. We developed a pan-genotypic (genotypes A-J) HBV scheme using an early version of PrimalScheme3, a web-based primer design tool for developing multiplex primer schemes. PrimalScheme3 is a successor to PrimalScheme, with a number of changes made to enable us to generate an overlapping (tiled) amplicon scheme which covered the circular HBV genome, utilising a number of discrete primers at each position to handle intraspecies diversity. Primer sequences https://github.com/quick-lab/primerschemes/blob/main/primerschemes/hbv/600/v2.1.0/primer.bed The amplicons can also be fragmented and sequenced on Illumina platforms. Recommended extraction protocol We use the QIAamp minelute virus spin kit with carrier RNA. For samples with VL >5log IU/ml we extract from 200ul of sample using the manufacturers protocol, for samples with VL <5log IU/ml we extract from 400ul sample doubling up the protease, AL and ethanol.